Literature DB >> 3191766

Endobronchial tuberculosis in the acquired immunodeficiency syndrome.

L S Wasser1, G W Shaw, W Talavera.   

Abstract

Although many of the pulmonary manifestations of tuberculosis in the acquired immunodeficiency syndrome (AIDS) are well known, endobronchial involvement has not been previously described. We report the clinical, roentgenographic, and bronchoscopic features of three patients with endobronchial tuberculosis and AIDS. All of the patients had nonspecific symptoms of fever and cough; however, none exhibited the classic findings of dyspnea, wheezing, or hemoptysis. Smears of sputum were nondiagnostic. The chest x-ray film revealed mediastinal adenopathy in two patients and a lower lobe consolidation in the third; all had small ipsilateral pleural effusions. Endobronchial lesions were white or pink exophytic masses obstructing the airways, mimicking bronchogenic carcinoma. Areas of "classic" primary tuberculosis were seen in two of the patients. Despite ongoing clinical and roentgenographic deterioration, all patients responded well to antituberculosis medications. Given the frequency of tuberculosis in patients with AIDS and AIDS-related complex, one should maintain a high index of suspicion for involvement of the tracheobronchial tree, so as to avoid a delay in diagnosis and resultant increased morbidity and mortality.

Entities:  

Mesh:

Year:  1988        PMID: 3191766     DOI: 10.1378/chest.94.6.1240

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  3 in total

1.  Mixed bronchial infection due to Mycobacterium tuberculosis and Mycobacterium avium-intracellulare in an AIDS patient.

Authors:  M Libanore; R Bicocchi; F Ghinelli
Journal:  Infection       Date:  1992 Sep-Oct       Impact factor: 3.553

2.  Mycobacterial infections in AIDS.

Authors:  A R Hill
Journal:  Can J Infect Dis       Date:  1991

Review 3.  Imaging of pulmonary tuberculosis.

Authors:  P Van Dyck; F M Vanhoenacker; P Van den Brande; A M De Schepper
Journal:  Eur Radiol       Date:  2002-08-10       Impact factor: 5.315

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.